| Literature DB >> 10699267 |
R L Gutman1, G Peacock, D R Lu.
Abstract
The blood brain barrier (BBB) and the systemic toxicity of conventional chemotherapy present obstacles to the success of future blood-borne drug therapies of brain tumors. The work with polymer-encapsulated cancer drugs suggests an alternative and more focused treatment approach. Our experimental strategy integrates direct intracerebral drug delivery, sustained drug release from liposomes or polymer implants, and increased targeting of the drug either by chemically modifying the drug or by using tumor-specific carriers. This review will present some of the recent work on targeted drug delivery for brain cancer treatment.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10699267 DOI: 10.1016/s0168-3659(99)00229-1
Source DB: PubMed Journal: J Control Release ISSN: 0168-3659 Impact factor: 9.776